Escalon Medical Corp. (ESMC)

Market Cap	2.81M
Revenue (ttm)	12.95M
Net Income (ttm)	355.37K
Shares Out	7.42M
EPS (ttm)	0.05
PE Ratio	7.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	475
Average Volume	8,884
Open	0.3796
Previous Close	0.3212
Day's Range	0.3796 - 0.3796
52-Week Range	0.1130 - 0.4625
Beta	0.41
RSI	59.82
Earnings Date	Sep 29, 2025

About Inozyme Pharma

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachyme...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 40
• Stock Exchange: OTCMKTS
• Ticker Symbol: ESMC